# 4661
A little caveat emptor this morning with this story from the FDA on their testing of `generic tamiflu’ that was sold online without requiring a prescription.
Not only did it not contain any oseltamivir – it was laced with cloxacillin, a penicillin like antibiotic that could cause serious (and potentially fatal) anaphylactic reactions in some recipients.
FDA Sounds Alarm on Phony Tamiflu
The FDA is warning consumers that a phony version of an antiviral drug being sold on the Internet could spark a harmful reaction in some people.
Investigators found the drug was being sold as “generic Tamiflu,” even though FDA has not approved a generic version of Tamiflu, which is used in treatment of the flu.
The unapproved medication contains cloxacillin, an ingredient in the same class as penicillin. FDA warned that the unlabeled product could result in a life-threatening reaction in persons who are allergic to penicillin.
FDA investigators bought the fake Tamiflu without a prescription on the Internet, even though a prescription is required to buy Tamiflu in legitimate pharmacies. Later, two foil-backed blister packages with a total of 30 yellow and tan capsules arrived in an envelope postmarked India. The product label claimed to be 75 mg. capsules of oseltamivir phosphate, but testing proved otherwise.
Laboratory tests conducted by FDA showed the product did not contain oseltamivir, the active ingredient in Tamiflu. Instead, the fraudulent medication contained cloxacillin.
Related Post:
- CDC HAN Update On Fungal Meningitis Outbreak
- FDA: Ameridose Announces Voluntary Recall Of All Products
- FDA Statement On Conditions Reported At NECC Facility
- The Narrow Margin
- FDA: Exserohilum Found In Unopened Vials Of NECC Methylprednisolone
- CDC/FDA: Multistate Fungal Meningitis Outbreak – Oct 15th
- CDC Update: Multi State Meningitis Outbreak – Oct 11th
- FDA Advice On Safe Use Of Neti Pots
- FDA Warning On Fake Adderall
- FDA Statement On Azithromycin & Cardiovascular Risks
- FDA Releases 2nd Edition Of the `Bad Bug Book’
- Kids, Colds, And OTC Meds
- FDA Approves 2011-2012 Seasonal Influenza Vaccines
- Because Everyday Is Fry Day
- Poll: Despite FDA Warning Parents Use OTC Cold Remedies For Kids Under 2
- FDA: Fluzone Vaccine Safety
- Salmonella-Related Egg Recall Expands
- Study: MLV Found In CFS Patients
- CDC Investigating Food-Related Typhoid Outbreak
- FDA Approves 2010-2011 Flu Vaccines
- FDA Farm Antibiotic Guidance Meets Resistance
- FDA Calls For Temporary Halt To Using Rotarix Vaccine
- FDA Warning On Extortion Scam
- Flu Email Scams
- Canada Releases Tamiflu From National Emergency Stockpile
- Study: The Benefits Of Antiviral Therapy During the 2009 Pandemic
- Study: Adverse Events Associated With Oseltamivir Outpatient Treatment
- The CDC Responds To The Cochrane Group’s Tamiflu Study
- The Tamiflu Controversy Continues
- NEJM: Oseltamivir Resistant H1N1 in Australia
- CIDRAP News: Signs Of Tamiflu Resistant H1N1 Spreading
- Australia Reports Cluster Of Antiviral Resistant H1N1
- The WHO’s Flu Review
- CIDRAP: UK Findings Hint At Resistant Flu Strain
- Study: Oseltamivir-Resistant Pandemic Flu Cases In The US
- PLoS Medicine: Mono or Combo Antiviral Therapy?
- BMJ: Efficacy of Oseltamivir In Mild H1N1
- Study: Antiviral Therapy For H5N1
- Fitness Of Oseltamivir-Resistant A/H1N1/2009
- Study: Oseltamivir Treatment of Infants Under One Year
- Caltech: How Seasonal Flu Gained Tamiflu Resistance
- Eurosurveillance: Adverse Effects of Oseltamivir in Children
- NIH: Rapid Development Of Antiviral Resistance In Two Cases
- The Path Of Increased Resistance
- UK: National Pandemic Flu Service Stands Down
- WER Review: Oseltamivir Resistance In Pandemic H1N1
- South Korea Reports A Tamiflu-Resistant H1N1 Fatality
- Referral: Effect Measure On The BMJ Tamiflu Story
Widget by [ Iptek-4u ]